ReCode Therapeutics

1 follower

‌

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.

Industries

Biotechnology

Headquarters

Menlo Park, United States

Employees

51-200

Links

Org chart

Shehnaaz Suliman

CEO

Shehnaaz Suliman

Collapse

David J Lockhart

President & Chief Scientific Officer

Vladimir G. Kharitonov

SVP, CMC

April Loui

SVP, Quality & CMC Regulatory Affairs

John G. Matthews

SVP, Clinical Development

Erica V. Jefferson

SVP, Corporate Affairs

Daniel Siegwart

Co-Founder

Eneda Hoxha

Vice President, Intellectual Property & Business Development

Heather Clark

Svp, CF Franchise Lead

Sakya Mohapatra

Senior Director, Formulation and Process Development

Teri Keffer

Head Of People

Ariel Kantor

Vice President, Business Development & Platform Strategy

Max Barker

SVP, Legal Affairs & Business Operations

Carol Wolf

Senior Director, Accounting & Assistant Controller

Board & advisors

Director

Director

Director

Director

Director

Director

Director

Chair, Scientific Advisory Board

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Teams

+32

Research and Development

35 members

+10

Directors Team

13 members

Leadership Team

3 members

Business Development & Strategy

6 members

Human Resources and Operations

6 members

Research and Development

4 members

Offices

Similar companies

Immunovant

6 followers

Bolt Biotherapeutics

6 followers

C4 Therapeutics

5 followers

Summit Therapeutics

5 followers

Owkin

4 followers

Stemline Therapeutics

3 followers

AnaptysBio

3 followers

Rigel Pharmaceuticals

3 followers

Arcturus Therapeutics

2 followers

Arcutis Biotherapeutics

2 followers

ACROBiosystems

2 followers

Explore companies